(Q37161528)

18 August 2017

The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study (English)

1 reference

18 August 2017

1 reference

3

Lars Slørdal

1 reference

18 August 2017

Pål Gjerden

1

1 reference

18 August 2017

Jørgen G Bramness

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

16 December 2008

1 reference

British Journal of Clinical Pharmacology

18 August 2017

1 reference

18 August 2017

67

1 reference

18 August 2017

2

1 reference

18 August 2017

228-233

1 reference

Carisoprodol use and abuse in Norway: a pharmacoepidemiological study

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Substance abuse in patients with schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Drug utilization statistics for individual-level pharmacy dispensing data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES III).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Postmarketing surveillance for drug abuse

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Anticholinergic drugs used in Parkinson's disease: An overlooked class of drugs from a pharmacokinetic perspective

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Difference between single and multiple dose pharmacokinetics of orphenadrine hydrochloride in man.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Clinical and Pharmacological Review of the Efficacy of Orphenadrine and Its Combination with Paracetamol in Painful Conditions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Use or abuse of antiparkinsonian drugs by psychiatric patients.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Misuse of anticholinergic drugs by people with serious mental illness.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Patterns of current and lifetime substance use in schizophrenia.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

Fatalities caused by anticholinergic antiparkinsonian drugs. Analysis of findings in a 11-year national material

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670380

A nation-wide study on the practice of euthanasia and physician-assisted suicide in community and hospital pharmacies in The Netherlands

3 September 2018

1 reference

12 December 2020

A study of benzhexol abuse

1 reference

12 December 2020

Trihexyphenidyl (Artane) abuse in schizophrenic patients

1 reference

12 December 2020

[Clinical pharmacology of anticholinergic antiparkinson agents. A review with emphasis on acute toxicity]

1 reference

12 December 2020

Fatal toxicity of drugs used in the treatment of psychotic illnesses

1 reference

12 December 2020

10.1111/J.1365-2125.2008.03342.X

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19094158

1 reference